Reply to Wong et al

Abstract
To the Editor—We read with great interest the letter by Wong et al regarding our recently published article, “Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry” [1, 2].